Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/7/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Janet R. Greeson Ph.D.

Wrong Dr. Janet R. Greeson Ph.D.?

Chief Executive Officer

Phone: (702) ***-****  
Samaritan Pharmaceuticals Inc
101 Convention Center Drive Suite 310
Las Vegas , Nevada 89109
United States

Company Description: Samaritan Pharmaceuticals, Inc. (Samaritan) is an entrepreneurial biopharmaceutical company, focused on commercializing therapeutic products to relieve the...   more
Background

Board Memberships and Affiliations

  • Board Member
    Mother Theresa
  • Founder
    BB Strategists , Inc.
  • Co-Founder
    The Research Works Inc

Education

  • Hotel/Restaurant Management
    University of Michigan at Mid-Florida
  • Motel Hotel Management
  • BA
    Florida Technological University
  • Jurist Doctorate Candidate
  • MA
    Rollins College
  • MA degree , Motel Hotel Management
    Rollins College , Orlando , Florida ,
  • MBA Candidate
    University of Southern California
  • PhD
    Columbia Pacific University
  • doctorate , Psychology
    Columbia-Pacific University
  • doctorate , Psychology
    Columbia-Pacific University , Mill Valley , California ,
199 Total References
Web References
Stockupticks - Home
www.stockupticks.com [cached]
Dr. Janet Greeson, CEO of Samaritan stated, "We remain enthusiastically confident in the promise of SP01A.
...
Dr. Greeson, CEO of Samaritan Pharmaceuticals, stated, "We are completely excited about SP-233 (Caprospinol) as a totally new approach to treat Alzheimer's disease. Dr. Greeson continued, "We have been aggressively pushing to file an investigational new drug (IND) application for Caprospinol and this is one of the many milestones we have had to achieve to get there."
...
Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals stated, "We are extremely pleased with our collaboration with Georgetown University, it gives us the ability to continually, build and grow, our pipeline of innovative drugs.
...
Dr. Janet Greeson - Chief Executive Officer, President and Director
Dr. Janet Greeson, Chairman, President and CEO, led the bold initiative that transformed Samaritan from a "one drug" Company to an innovative "Drug Development Pipeline" Biopharmaceutical Company. She strategically created a long-term value and growth model, with the Samaritan/Georgetown University collaboration; and intends to duplicate this growth model with other top tier Universities, as a solid strategy to continually build Samaritan's value and sustain its future profitability.
Dr. Greeson is a successful healthcare professional with over two decades of corporate experience focused on emerging growth situations, leadership development, and mergers and acquisitions. Although she has worked with Samaritan for nine years, as CEO for the past four years she has demonstrated a relentless perseverance and determination to succeed in the face of unrelenting change. She is extremely motivated and equipped to attack problems and seize realistic opportunities, with capability, courage and confidence.
Dr. Greeson is a co-inventor of 18 patent applications, and presently has nine "peer reviewed" journal publications. She is a best selling author of "It's Not What You Are Eating, It's What's Eating You"; and a renowned public speaker, whose guest appearances on numerous radio and TV Talk shows, has opened the door to tell the Samaritan story, in a concise and professional manner.
Dr. Greeson is an experienced growth "Model" developer. In the past, Dr. Greeson developed model "Addiction Rehab Programs" for the US Navy, and went on privately, to develop and grow a nationwide "inpatient treatment program model" which she later sold to Columbia/HCA (NYSE:COL).
Dr. Greeson has an eclectic past, once working with Mother Theresa and was privileged to be the U.S. Congressional Nominee for the State of Nevada in 1994, winning the primary without spending a dollar to campaign. She currently fulfills her altruistic energies with the Samaritan Innovative Science Foundation.
Dr. Greeson holds a BA, from Florida Technological University 1978; an MA from Rollins College 1979; a PhD from Columbia Pacific University 1987.
Dr. Greeson devotes substantially all of her time to the affairs of Samaritan Pharmaceuticals.
Stockupticks - Home
www.stockupticks.com [cached]
Although it is early stage, each preclinical study we accomplish gives us hope that we might have an extraordinary treatment for the mind robbing disease of Alzheimer's," stated Dr. Greeson, CEO of Samaritan.
...
Dr. Janet Greeson, CEO of Samaritan stated, "We remain enthusiastically confident in the promise of SP01A.
...
Dr. Greeson, CEO of Samaritan Pharmaceuticals, stated, "We are completely excited about SP-233 (Caprospinol) as a totally new approach to treat Alzheimer's disease. Dr. Greeson continued, "We have been aggressively pushing to file an investigational new drug (IND) application for Caprospinol and this is one of the many milestones we have had to achieve to get there."
...
Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals stated, "We are extremely pleased with our collaboration with Georgetown University, it gives us the ability to continually, build and grow, our pipeline of innovative drugs.
Stockupticks - Home
www.stockupticks.com [cached]
Dr. Greeson, CEO of Samaritan Pharmaceuticals stated, "Clinically SP-01A has always been tested in concert with other antiretroviral drugs, this is the first time it was tested alone. We are very encouraged with the results and look forward to developing SP-01A to hopefully be the first orally administered entry cell inhibitor drug with a 'firewall' mechanism of action. Dr. Greeson went on to say, "We started our Phase II 28-day monotherapy study and we are continuing to enroll patients.
...
Dr. Janet Greeson, CEO of Samaritan stated, "Completing this 10 day HIV monotherapy study of SP01A is a significant milestone in its clinical development.
...
Dr. Janet Greeson, CEO of Samaritan stated, "We remain enthusiastically confident in the promise of SP01A.
Zurich 2007 Speakers
www.sachsforum.com [cached]
Dr Janet Greeson, Chief Executive Officer, Samaritan Pharmaceuticals
Samaritan Pharma Retains The Investor Relations Group of New York
www.samaritanpharma.com [cached]
Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals commented, "We have made substantial accomplishments in developing our clinical development pipeline, as well as establishing numerous collaborative relationships with specialty pharmaceutical companies to market and sell their approved prescription drugs in Greece and Eastern Europe. As we move forward with our growth strategy, we feel the timing is right for The Investor Relations Group to play an integral role in communicating Samaritan's message to the investment community and the media-at-large.''
"...As we move forward with our growth strategy, we feel the timing is right for The Investor Relations Group to play an integral role in communicating Samaritan's message to the investment community and the media-at-large.''
Dr. Janet Greeson CEO Samaritan Pharmaceuticals
...
Audio Interview with Dr. Janet Greeson
...
Audio Interview with Dr. Janet Greeson
...
Audio Interview with Dr. Janet Greeson
...
Audio Interview with Dr. Janet Greeson
Samaritan Pharma Completes Acquisition of Metastatin Pharmaceuticals
Other People with the name "Greeson":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304